Volume 90, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Cysticercosis is a potentially fatal and preventable neglected parasitic infection caused by the larval form of . Patients with symptomatic disease usually have signs and symptoms of neurocysticercosis, which commonly manifest as seizures or increased intracranial pressure. Although there are many persons living in the United States who emigrated from highly disease-endemic countries and there are foci of autochthonous transmission of the parasite in the United States, little is known about burden and epidemiology of the disease in this country. In addition, despite advances in the diagnosis and management of neurocysticercosis, there remain many unanswered questions. Improving our understanding and management of neurocysticercosis in the United States will require improved surveillance or focused prospective studies in appropriate areas and allocation of resources towards answering some of the key questions discussed in this report.

[open-access] This is an Open Access article distributed under the terms of the American Society of Tropical Medicine and Hygiene's Re-use License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian YJ, Rainwater E, Dickey M, Reynolds S, Stoner JA, , 2010. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis 4: e870.[Crossref] [Google Scholar]
  2. Bern C, Garcia HH, Evans C, Gonzalez AE, Verastegui M, Tsang VC, Gilman RH, , 1999. Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis 29: 12031209.[Crossref] [Google Scholar]
  3. Medina MT, Rosas E, Rubio-Donnadieu F, Sotelo J, , 1990. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 150: 325327.[Crossref] [Google Scholar]
  4. Garcia HH, Del Brutto OH, Cysticercosis Working Group in Peru, , 2005. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 4: 653661.[Crossref] [Google Scholar]
  5. Wallin MT, Kurtzke JF, , 2004. Neurocysticercosis in the United States: review of an important emerging infection. Neurology 63: 15591564.[Crossref] [Google Scholar]
  6. Ong S, Talan DA, Moran GJ, Mower W, Newdow M, Tsang VC, Pinner RW, Group EMINS, , 2002. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 8: 608613.[Crossref] [Google Scholar]
  7. Garcia HH, Gonzalez AE, Evans CA, Gilman RH, Cysticercosis Working Group in Peru, , 2003. Taenia solium cysticercosis. Lancet 362: 547556.[Crossref] [Google Scholar]
  8. Garcia HH, Del Brutto OH, , 2003. Imaging findings in neurocysticercosis. Acta Trop 87: 7178.[Crossref] [Google Scholar]
  9. Carabin H, Ndimubanzi PC, Budke CM, Nguyen H, Qian Y, Cowan LD, Stoner JA, Rainwater E, Dickey M, , 2011. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis 5: e1152.[Crossref] [Google Scholar]
  10. Garcia HH, Del Brutto OH, Nash TE, White AC, Jr Tsang VC, Gilman RH, , 2005. New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg 72: 39. [Google Scholar]
  11. Nash TE, Singh G, White AC, Rajshekhar V, Loeb JA, Proano JV, Takayanagui OM, Gonzalez AE, Butman JA, DeGiorgio C, Del Brutto OH, Delgado-Escueta A, Evans CA, Gilman RH, Martinez SM, Medina MT, Pretell EJ, Teale J, Garcia HH, , 2006. Treatment of neurocysticercosis: current status and future research needs. Neurology 67: 11201127.[Crossref] [Google Scholar]
  12. Fleury A, Carrillo-Mezo R, Flisser A, Sciutto E, Corona T, , 2011. Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti Infect Ther 9: 123133.[Crossref] [Google Scholar]
  13. Nash T, , 2012. Edema surrounding calcified intracranial cysticerci: clinical manifestations, natural history, and treatment. Pathog Glob Health 106: 275279.[Crossref] [Google Scholar]
  14. Nash TE, Pretell EJ, Lescano AG, Bustos JA, Gilman RH, Gonzalez AE, Garcia HH, Cysticercosis Working Group in Peru, , 2008. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol 7: 10991105.[Crossref] [Google Scholar]
  15. Ooi WW, Wijemanne S, Thomas CB, Quezado M, Brown CR, Nash TE, , 2011. Short report: a calcified Taenia solium granuloma associated with recurrent perilesional edema causing refractory seizures: histopathological features. Am J Trop Med Hyg 85: 460463.[Crossref] [Google Scholar]
  16. Serpa JA, Graviss EA, Kass JS, White AC, Jr, 2011. Neurocysticercosis in Houston, Texas: an update. Medicine (Baltimore) 90: 8186.[Crossref] [Google Scholar]
  17. Figueroa JJ, Davis LE, Magalhaes A, , 2011. Extraparenchymal neurocysticercosis in Albuquerque, New Mexico. J Neuroimaging 21: 3843.[Crossref] [Google Scholar]
  18. Cantu C, Barinagarrementeria F, , 1996. Cerebrovascular complications of neurocysticercosis. Clinical and neuroimaging spectrum. Arch Neurol 53: 233239.[Crossref] [Google Scholar]
  19. Callacondo D, Garcia HH, Gonzales I, Escalante D, Nash TE, Cysticercosis Working Group in Peru, , 2012. High frequency of spinal involvement in patients with basal subarachnoid neurocysticercosis. Neurology 78: 13941400.[Crossref] [Google Scholar]
  20. Lerner A, Shiroishi MS, Zee CS, Law M, Go JL, , 2012. Imaging of neurocysticercosis. Neuroimaging Clin N Am 22: 659676.[Crossref] [Google Scholar]
  21. Feldman M, Plancarte A, Sandoval M, Wilson M, Flisser A, , 1990. Comparison of two assays (EIA and EITB) and two samples (saliva and serum) for the diagnosis of neurocysticercosis. Trans R Soc Trop Med Hyg 84: 559562.[Crossref] [Google Scholar]
  22. Wilson M, Bryan RT, Fried JA, Ware DA, Schantz PM, Pilcher JB, Tsang VC, , 1991. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 164: 10071009.[Crossref] [Google Scholar]
  23. Rodriguez S, Wilkins P, Dorny P, , 2012. Immunological and molecular diagnosis of cysticercosis. Pathog Glob Health 106: 286298.[Crossref] [Google Scholar]
  24. Zea-Vera A, Cordova EG, Rodriguez S, Gonzales I, Pretell EJ, Castillo Y, Castro-Suarez S, Gabriel S, Tsang VC, Dorny P, Garcia HH, for the Cysticercosis Working Group in Peru, , 2013. Parasite antigen in serum predicts the presence of viable brain parasites in patients with apparently calcified cysticercosis only. Clin Infect Dis 57: e154e159.[Crossref] [Google Scholar]
  25. Rodriguez S, Dorny P, Tsang VC, Pretell EJ, Brandt J, Lescano AG, Gonzalez AE, Gilman RH, Garcia HH, Cysticercosis Working Group in Peru, , 2009. Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J Infect Dis 199: 13451352.[Crossref] [Google Scholar]
  26. Bustos JA, Rodriguez S, Jimenez JA, Moyano LM, Castillo Y, Ayvar V, Allan JC, Craig PS, Gonzalez AE, Gilman RH, Tsang VC, Garcia HH, Cysticercosis Working Group in Peru, , 2012. Detection of Taenia solium taeniasis coproantigen is an early indicator of treatment failure for taeniasis. Clin Vaccine Immunol 19: 570573.[Crossref] [Google Scholar]
  27. Guezala MC, Rodriguez S, Zamora H, Garcia HH, Gonzalez AE, Tembo A, Allan JC, Craig PS, , 2009. Development of a species-specific coproantigen ELISA for human Taenia solium taeniasis. Am J Trop Med Hyg 81: 433437. [Google Scholar]
  28. Allan JC, Wilkins PP, Tsang VC, Craig PS, , 2003. Immunodiagnostic tools for taeniasis. Acta Trop 87: 8793.[Crossref] [Google Scholar]
  29. Nash TE, Mahanty S, Garcia HH, Cysticercosis Group in Peru, , 2011. Corticosteroid use in neurocysticercosis. Expert Rev Neurother 11: 11751183.[Crossref] [Google Scholar]
  30. Garcia HH, Gonzalez AE, Gilman RH, , 2011. Cysticercosis of the central nervous system: how should it be managed? Curr Opin Infect Dis 24: 423427.[Crossref] [Google Scholar]
  31. Rajshekhar V, , 2010. Surgical management of neurocysticercosis. Int J Surg 8: 100104.[Crossref] [Google Scholar]
  32. Maguire JH, , 2004. Tapeworms and seizures–treatment and prevention. N Engl J Med 350: 215217.[Crossref] [Google Scholar]
  33. Centers for Disease Control and Prevention, 1992. Locally acquired neurocysticercosis–North Carolina, Massachusetts, and South Carolina, 1989–1991. MMWR Morb Mortal Wkly Rep 41: 14. [Google Scholar]
  34. Asnis D, Kazakov J, Toronjadze T, Bern C, Garcia HH, McAuliffe I, Bishop H, Lee L, Grossmann R, Garcia MA, Di John D, , 2009. Neurocysticercosis in the infant of a pregnant mother with a tapeworm. Am J Trop Med Hyg 81: 449451. [Google Scholar]
  35. Daniels TL, Moore TA, , 2006. Neurocysticercosis in Kansas. Ann Intern Med 144: 150152.[Crossref] [Google Scholar]
  36. Moore AC, Lutwick LI, Schantz PM, Pilcher JB, Wilson M, Hightower AW, Chapnick EK, Abter EI, Grossman JR, Fried JA, , 1995. Seroprevalence of cysticercosis in an Orthodox Jewish community. Am J Trop Med Hyg 53: 439442. [Google Scholar]
  37. Rosenfeld EA, Byrd SE, Shulman ST, , 1996. Neurocysticercosis among children in Chicago. Clin Infect Dis 23: 262268.[Crossref] [Google Scholar]
  38. McCormick GF, , 1985. Cysticercosis: review of 230 patients. Bull Clin Neurosci 50: 76101. [Google Scholar]
  39. Sorvillo FJ, Waterman SH, Richards FO, Schantz PM, , 1992. Cysticercosis surveillance: locally acquired and travel-related infections and detection of intestinal tapeworm carriers in Los Angeles County. Am J Trop Med Hyg 47: 365371. [Google Scholar]
  40. Schantz PM, Moore AC, Munoz JL, Hartman BJ, Schaefer JA, Aron AM, Persaud D, Sarti E, Wilson M, Flisser A, , 1992. Neurocysticercosis in an Orthodox Jewish community in New York City. N Engl J Med 327: 692695.[Crossref] [Google Scholar]
  41. Barton Behravesh C, Mayberry LF, Bristol JR, Cardenas VM, Mena KD, Martinez-Ocana J, Flisser A, Snowden KF, , 2008. Population-based survey of taeniasis along the United States–Mexico border. Ann Trop Med Parasitol 102: 325333.[Crossref] [Google Scholar]
  42. DeGiorgio C, Pietsch-Escueta S, Tsang V, Corral-Leyva G, Ng L, Medina MT, Astudillo S, Padilla N, Leyva P, Martinez L, Noh J, Levine M, del Villasenor R, Sorvillo F, , 2005. Sero-prevalence of Taenia solium cysticercosis and Taenia solium taeniasis in California, USA. Acta Neurol Scand 111: 8488.[Crossref] [Google Scholar]
  43. Ciesielski S, Seed JR, Estrada J, Wrenn E, , 1993. The seroprevalence of cysticercosis, malaria, and Trypanosoma cruzi among North Carolina migrant farmworkers. Public Health Rep 108: 736741. [Google Scholar]
  44. Ehnert KL, Roberto RR, Barrett L, Sorvillo FJ, Rutherford GW, 3rd, 1992. Cysticercosis: first 12 months of reporting in California. Bull Pan Am Health Organ 26: 165172. [Google Scholar]
  45. O'Neal S, Noh J, Wilkins P, Keene W, Lambert W, Anderson J, Compton Luman J, Townes J, , 2011. Taenia solium tapeworm infection, Oregon, 2006–2009. Emerg Infect Dis 17: 10301036.[Crossref] [Google Scholar]
  46. Townes JM, Hoffmann CJ, Kohn MA, , 2004. Neurocysticercosis in Oregon, 1995–2000. Emerg Infect Dis 10: 508510.[Crossref] [Google Scholar]
  47. Croker C, Redelings M, Reporter R, Sorvillo F, Mascola L, Wilkins P, , 2012. The impact of neurocysticercosis in california: a review of hospitalized cases. PLoS Negl Trop Dis 6: e1480.[Crossref] [Google Scholar]
  48. Henneman PL, DeRoos F, Lewis RJ, , 1994. Determining the need for admission in patients with new-onset seizures. Ann Emerg Med 24: 11081114.[Crossref] [Google Scholar]
  49. del la Garza Y, Graviss EA, Daver NG, Gambarin KJ, Shandera WX, Schantz PM, White AC, Jr, 2005. Epidemiology of neurocysticercosis in Houston, Texas. Am J Trop Med Hyg 73: 766770. [Google Scholar]
  50. Croker C, Reporter R, Mascola L, , 2010. Use of statewide hospital discharge data to evaluate the economic burden of neurocysticercosis in Los Angeles County (1991–2008). Am J Trop Med Hyg 83: 106110.[Crossref] [Google Scholar]
  51. Sorvillo FJ, DeGiorgio C, Waterman SH, , 2007. Deaths from cysticercosis, United States. Emerg Infect Dis 13: 230235.[Crossref] [Google Scholar]
  52. Coyle CM, Mahanty S, Zunt JR, Wallin MT, Cantey PT, White AC, Jr O'Neal SE, Serpa JA, Southern PM, Wilkins P, McCarthy AE, Higgs ES, Nash TE, , 2012. Neurocysticercosis: neglected but not forgotten. PLoS Negl Trop Dis 6: e1500.[Crossref] [Google Scholar]
  53. Flisser A, Sarti E, Lightowlers M, Schantz P, , 2003. Neurocysticercosis: regional status, epidemiology, impact and control measures in the Americas. Acta Trop 87: 4351.[Crossref] [Google Scholar]
  54. O'Neal SE, Robbins NM, Townes JM, , 2012. Neurocysticercosis among resettled refugees from Burma. J Travel Med 19: 118121.[Crossref] [Google Scholar]
  55. O'Neal SE, Townes JM, Wilkins PP, Noh JC, Lee D, Rodriguez S, Garcia HH, Stauffer WM, , 2012. Seroprevalence of antibodies against Taenia solium cysticerci among refugees resettled in United States. Emerg Infect Dis 18: 431438.[Crossref] [Google Scholar]
  56. Sorvillo F, Wilkins P, Shafir S, Eberhard M, , 2011. Public health implications of cysticercosis acquired in the United States. Emerg Infect Dis 17: 16.[Crossref] [Google Scholar]
  57. Richards FO, Jr Schantz PM, Ruiz-Tiben E, Sorvillo FJ, , 1985. Cysticercosis in Los Angeles County. JAMA 254: 34443448.[Crossref] [Google Scholar]
  58. Del Brutto O, , 2012. Neurocysticercosis among international travelers to disease-endemic areas. J Travel Med 19: 112117.[Crossref] [Google Scholar]
  59. Bobes RJ, Hernandez M, Marquez C, Fragoso G, Garcia E, Parkhouse RM, Harrison LJ, Sciutto E, Fleury A, , 2006. Subarachnoidal and intraventricular human neurocysticercosis: application of an antigen detection assay for the diagnosis and follow-up. Trop Med Int Health 11: 943950.[Crossref] [Google Scholar]
  60. Deckers N, Dorny P, , 2010. Immunodiagnosis of Taenia solium taeniosis/cysticercosis. Trends Parasitol 26: 137144.[Crossref] [Google Scholar]
  • Received : 10 Dec 2013
  • Accepted : 14 Feb 2014
  • Published online : 07 May 2014

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error